Table 2 Multivariate analyses of predictors for distant disease-free survival and overall survival (n = 582)
Factor | HR | (95% CI) | p value |
|---|---|---|---|
Age (≤ 55 vs. > 55) | 1.3 | (0.55–3.33) | 0.56 |
T factor (T2 vs. T1) | 1.56 | (0.66–3.64) | 0.3 |
SLN factor (SLN+ vs. SLN−) | 1.42 | (0.56–3.36) | 0.44 |
ER (positive vs. negative) | 0.81 | (0.26–2.7) | 0.73 |
PgR (positive vs. negative) | 1.21 | (0.42–3.82) | 0.73 |
HER2 (positive vs. negative) | 0.64 | (0.20–1.69) | 0.38 |
Nuclear grade (3 vs. 1, 2) | 1.39 | (0.53–3.64) | 0.51 |
Ki67 | |||
Ki67 (< 14% vs. ≥ 14%) | 3.16 | (0.99–14.02) | 0.051 |
Ki67 (continuous value) | 1.03 | (1.01–1.05) | 0.017 |
Adjuvant chemotherapy (yes vs. no) | 1.2 | (0.48–3.09) | 0.69 |
Adjuvant radiotherapy (yes vs. no) | 0.71 | (0.31–1.69) | 0.29 |